NEW YORK, April 23 -- Acacia Research's CombiMatrix unit will make its new severe acute respiratory syndrome microarrays available to "key government and academic researchers," the company said today.
"Due to the public health and economic implications of SARS, we have decided to offer a limited number of SARS microarrays at no cost to key research centers," said Amit Kumar, president and CEO of CombiMatrix.
CombiMatrix last week said it had created the microarrays less than 48 hours after US and Canadian researchers sequenced the genome of the coronavirus. CombiMatrix scientists took the SARS sequence data and used the company's informatics systems to develop probes, and then manufacture the chips, the firm said.
It was not immediately clear which government or academic researchers are considered "key."
GenomeWeb coverage of SARS
Canadian Team Sequencing SARS Virus (Apr 9, 2003)
CDC Completes SARS Virus Genome Draft On Heels of Canadian Team (April 14, 2003)
Canadian Team Leader: SARS Coronavirus Genome Has 11 Novel ORFs (April 15, 2003)
CombiMatrix Creates Microarray Based on SARS Genome Data (April 16, 2003)
Coronavirus Linked to SARS: WHO (April 16, 2003)
Singapore Genome Institute Joins SARS Sequencing Fray (April 16, 2003)